Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16(INK4a)

Pamela Waber, Sandra Dlugosz, Qin Chang Cheng, John Truelson, Perry D. Nisen

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Although genetic alterations of chromosome band 9p21-22 occur frequently in head and neck squamous cell carcinoma (HNSCC) cell lines, alterations of the cyclin-dependent kinase inhibitor p16(INK4a) located in this region are less common in corresponding primary tumors. To further investigate genetic alterations at 9p21-22 and p16(INK4a) in primary HNSCC, a paired set of 21 tumors and blood specimens that were shown previously to exhibit allelic loss at 3p and elsewhere, were tested for LOH at 9p21-22 using eight different highly polymorphic marker. Sixteen of the samples (81%) exhibited LOH for at least one marker. Frequent LOH was found surrounding p16(INK4a) and at three additional noncontiguous regions of 9p21-22. No homozygous deletions were identified. SSCP screening and direct sequence analysis led to the identification of mutations the p16(INK4a) gene in two tumors. p16(INK4a) was not hypermethylated in any of the samples studied. Furthermore, there was no correlation between LOH at 9p21-22 and the RB1 tumor suppressor gene. These findings indicate that in the set of tumors that we tested, LOH at 9p21-22 is common in primary HNSCC but that genetic alterations of p16(INK4a) located in this region are unusual. Additional tumor suppressor genes at 9p21-22 may therefore be involved in the pathogenesis of this tumor.

Original languageEnglish (US)
Pages (from-to)1699-1704
Number of pages6
JournalOncogene
Volume15
Issue number14
StatePublished - 1997

Fingerprint

Head and Neck Neoplasms
Chromosomes
Neoplasms
Tumor Suppressor Genes
Cyclin-Dependent Kinase Inhibitor p16
p16 Genes
Single-Stranded Conformational Polymorphism
Loss of Heterozygosity
Sequence Analysis
Cell Line
Mutation
Carcinoma, squamous cell of head and neck

Keywords

  • Chromosome 9
  • Cyclin-dependent kinase inhibitors
  • Loss of heterozygosity
  • P16(INK4a)
  • Squamous cell carcinoma of the head and neck

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Waber, P., Dlugosz, S., Cheng, Q. C., Truelson, J., & Nisen, P. D. (1997). Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16(INK4a). Oncogene, 15(14), 1699-1704.

Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16(INK4a). / Waber, Pamela; Dlugosz, Sandra; Cheng, Qin Chang; Truelson, John; Nisen, Perry D.

In: Oncogene, Vol. 15, No. 14, 1997, p. 1699-1704.

Research output: Contribution to journalArticle

Waber, P, Dlugosz, S, Cheng, QC, Truelson, J & Nisen, PD 1997, 'Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16(INK4a)', Oncogene, vol. 15, no. 14, pp. 1699-1704.
Waber, Pamela ; Dlugosz, Sandra ; Cheng, Qin Chang ; Truelson, John ; Nisen, Perry D. / Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16(INK4a). In: Oncogene. 1997 ; Vol. 15, No. 14. pp. 1699-1704.
@article{645b7715592a412da769b883adcd7236,
title = "Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16(INK4a)",
abstract = "Although genetic alterations of chromosome band 9p21-22 occur frequently in head and neck squamous cell carcinoma (HNSCC) cell lines, alterations of the cyclin-dependent kinase inhibitor p16(INK4a) located in this region are less common in corresponding primary tumors. To further investigate genetic alterations at 9p21-22 and p16(INK4a) in primary HNSCC, a paired set of 21 tumors and blood specimens that were shown previously to exhibit allelic loss at 3p and elsewhere, were tested for LOH at 9p21-22 using eight different highly polymorphic marker. Sixteen of the samples (81{\%}) exhibited LOH for at least one marker. Frequent LOH was found surrounding p16(INK4a) and at three additional noncontiguous regions of 9p21-22. No homozygous deletions were identified. SSCP screening and direct sequence analysis led to the identification of mutations the p16(INK4a) gene in two tumors. p16(INK4a) was not hypermethylated in any of the samples studied. Furthermore, there was no correlation between LOH at 9p21-22 and the RB1 tumor suppressor gene. These findings indicate that in the set of tumors that we tested, LOH at 9p21-22 is common in primary HNSCC but that genetic alterations of p16(INK4a) located in this region are unusual. Additional tumor suppressor genes at 9p21-22 may therefore be involved in the pathogenesis of this tumor.",
keywords = "Chromosome 9, Cyclin-dependent kinase inhibitors, Loss of heterozygosity, P16(INK4a), Squamous cell carcinoma of the head and neck",
author = "Pamela Waber and Sandra Dlugosz and Cheng, {Qin Chang} and John Truelson and Nisen, {Perry D.}",
year = "1997",
language = "English (US)",
volume = "15",
pages = "1699--1704",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "14",

}

TY - JOUR

T1 - Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16(INK4a)

AU - Waber, Pamela

AU - Dlugosz, Sandra

AU - Cheng, Qin Chang

AU - Truelson, John

AU - Nisen, Perry D.

PY - 1997

Y1 - 1997

N2 - Although genetic alterations of chromosome band 9p21-22 occur frequently in head and neck squamous cell carcinoma (HNSCC) cell lines, alterations of the cyclin-dependent kinase inhibitor p16(INK4a) located in this region are less common in corresponding primary tumors. To further investigate genetic alterations at 9p21-22 and p16(INK4a) in primary HNSCC, a paired set of 21 tumors and blood specimens that were shown previously to exhibit allelic loss at 3p and elsewhere, were tested for LOH at 9p21-22 using eight different highly polymorphic marker. Sixteen of the samples (81%) exhibited LOH for at least one marker. Frequent LOH was found surrounding p16(INK4a) and at three additional noncontiguous regions of 9p21-22. No homozygous deletions were identified. SSCP screening and direct sequence analysis led to the identification of mutations the p16(INK4a) gene in two tumors. p16(INK4a) was not hypermethylated in any of the samples studied. Furthermore, there was no correlation between LOH at 9p21-22 and the RB1 tumor suppressor gene. These findings indicate that in the set of tumors that we tested, LOH at 9p21-22 is common in primary HNSCC but that genetic alterations of p16(INK4a) located in this region are unusual. Additional tumor suppressor genes at 9p21-22 may therefore be involved in the pathogenesis of this tumor.

AB - Although genetic alterations of chromosome band 9p21-22 occur frequently in head and neck squamous cell carcinoma (HNSCC) cell lines, alterations of the cyclin-dependent kinase inhibitor p16(INK4a) located in this region are less common in corresponding primary tumors. To further investigate genetic alterations at 9p21-22 and p16(INK4a) in primary HNSCC, a paired set of 21 tumors and blood specimens that were shown previously to exhibit allelic loss at 3p and elsewhere, were tested for LOH at 9p21-22 using eight different highly polymorphic marker. Sixteen of the samples (81%) exhibited LOH for at least one marker. Frequent LOH was found surrounding p16(INK4a) and at three additional noncontiguous regions of 9p21-22. No homozygous deletions were identified. SSCP screening and direct sequence analysis led to the identification of mutations the p16(INK4a) gene in two tumors. p16(INK4a) was not hypermethylated in any of the samples studied. Furthermore, there was no correlation between LOH at 9p21-22 and the RB1 tumor suppressor gene. These findings indicate that in the set of tumors that we tested, LOH at 9p21-22 is common in primary HNSCC but that genetic alterations of p16(INK4a) located in this region are unusual. Additional tumor suppressor genes at 9p21-22 may therefore be involved in the pathogenesis of this tumor.

KW - Chromosome 9

KW - Cyclin-dependent kinase inhibitors

KW - Loss of heterozygosity

KW - P16(INK4a)

KW - Squamous cell carcinoma of the head and neck

UR - http://www.scopus.com/inward/record.url?scp=0030710484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030710484&partnerID=8YFLogxK

M3 - Article

C2 - 9349503

AN - SCOPUS:0030710484

VL - 15

SP - 1699

EP - 1704

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 14

ER -